Evidence map›Paper›PMID 40538756›Full record

ArticleFrontiers in physiology2025

H-DSAE: a hybrid technique to recognize heart disease.

K Uma Maheswari, A Valarmathi

Abstract read
In one paragraph

Article in Frontiers in physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

K Uma MaheswariDepartment of Information Technology, University College of Engineering, BIT Campus, Anna University, Tiruchirappalli, India.
A ValarmathiDepartment of Computer Applications, University College of Engineering, BIT Campus, Anna University, Tiruchirappalli, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the years, the number of people who succumbed to heart ailments has increased significantly worldwide. The World Health Organization claims that about 17 million people die each year due to heart disease. High levels of cholesterol and blood pressure are some risk factors. This technology seeks to treat these conditions before they become a problem. Through machine learning, doctors can now make more informed decisions regarding the treatment of patients. Machine learning can assist in reducing the likelihood of a cardiac event. Conventional methods for diagnosing diseases often lead to inaccurate diagnoses and take longer to complete due to human errors. In order to increase the diagnostic accuracy, an ensemble method is used. This method combines various classifiers to achieve highly accurate predictions. Due to the complexity of the task, the researchers decided to use deep learning methods to perform the heart disease classification task. H-DSAE technique utilize Deep Belief Network (DBN), Support Vector Machine (SVM), and Stacked Auto-Encoder (SAE). It was able to extract various heart image representations and achieve an accuracy of 99.2. It also had a sensitivity of 97.5, F-measure of 98.5, and precision of 98.4. The next phase of the project will focus on developing more advanced classification and features algorithms. This will help improve the efficiency of the system.

Indexed as

clinical decision makingDBNheart disease recognitionSAESVM

Identifiers

PMID40538756
PMCPMC12176601

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.